Lanxess Corp. has established a new site in Redmond, WA, to serve the pharmaceutical business line of its affiliate, Saltigo GmbH (a subsidiary of Lanxess Deutschland GmbH). The site includes offices, labs and technical facilities and provides Saltigo with U.S.-based pharmaceutical operations. 

 Saltigo plans to use the cGMP facilities of the kilo lab and pilot plant to produce APIs for early clinical testing through to Phase IIa. Timothy Fitzpatrick, former associate director of ICOS Corp...